Compounds > beta-lactams
Page last updated: 2024-09-04

beta-lactams and Communicable Diseases, Emerging

beta-lactams has been researched along with Communicable Diseases, Emerging in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lü, X; Zhang, L; Zong, Z1
Barth, AL; Martins, AF; Nordmann, P; Pagano, M; Poirel, L; Rozales, FP; Zavascki, AP1
Kazanji, N; Klein, RE; Le, J; Lohani, S; Mertens, AN1
Nordmann, P; Poirel, L; Toleman, MA; Walsh, TR1

Other Studies

4 other study(ies) available for beta-lactams and Communicable Diseases, Emerging

ArticleYear
The emergence of blaCTX-M-15-carrying Escherichia coli of ST131 and new sequence types in Western China.
    Annals of clinical microbiology and antimicrobials, 2013, Nov-27, Volume: 12

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; China; Communicable Diseases, Emerging; Escherichia coli; Escherichia coli Infections; Genes, Bacterial; Humans

2013
Emergence of NDM-1-producing Acinetobacter pittii in Brazil.
    International journal of antimicrobial agents, 2015, Volume: 45, Issue:4

    Topics: Acinetobacter; Acinetobacter Infections; Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Brazil; Communicable Diseases, Emerging; Genotype; Humans; Male; Microbial Sensitivity Tests; Mutagenesis, Insertional; Polymerase Chain Reaction

2015
A case of hypermucoviscous Klebsiella pneumoniae liver abscess syndrome in an Iraqi male.
    QJM : monthly journal of the Association of Physicians, 2016, Volume: 109, Issue:7

    Topics: Administration, Intravenous; Anti-Bacterial Agents; beta-Lactams; Communicable Diseases, Emerging; Decompression, Surgical; Drainage; Ertapenem; Humans; Iraq; Klebsiella Infections; Klebsiella pneumoniae; Liver Abscess; Male; Microbial Sensitivity Tests; Middle Aged; Syndrome; Treatment Outcome

2016
Does broad-spectrum beta-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria?
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:4

    Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Communicable Diseases, Emerging; Disease Transmission, Infectious; Escherichia coli; Escherichia coli Infections; Humans; India; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Mass Screening; Pakistan; Pandemics; Sweden; United Kingdom

2011